Showing 1-4 of 4 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Oxygen Enabled High-capacity Vascularized Devices for ß-cell Replacement Therapy in Humans | Arizona Board of Regents, University of Arizona | Klearchos Papas | Cures | 01-September-2023 to 31-August-2026 | $2,652,490.70 |
| Type 1 Diabetes Consortium – New Onset Workstream | Critical Path Institute (C-Path) | Joseph Hedrick | Cures | 28-October-2022 to 31-December-2025 | $1,132,723.00 |
| Type 1 Diabetes Consortium – Core and Prevention Workstream | Critical Path Institute (C-Path) | Sarah David | Cures | 01-July-2022 to 30-June-2025 | $800,270.00 |
| Developing Fit-For-Purpose Patient-reported Outcomes (PRO) Measure(s) in Type 1 Diabetes | Vector Psychometric Group | R. J. Wirth | Cures | 01-February-2025 to 31-March-2027 | $797,087.00 |